Allergy Medication

Verify with FDA CVM →

14 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
14
Total Reports
2
Deaths Reported
1430.0%
Death Rate

Active Ingredients

Allergy Medication

Administration Routes

UnknownOralSubcutaneous

Species Affected

Dog 12
Cat 2

Most Affected Breeds

Crossbred Canine/dog 3
Terrier - Yorkshire 2
Domestic Shorthair 2
Bulldog 1
Pekingese 1
Spaniel - Boykin 1
Bulldog - French 1
Terrier - Silky 1
Saluki 1
Shih Tzu 1

Most Reported Reactions

Lack of efficacy (ectoparasite) - flea 5
Vomiting 3
Pruritus 3
Seizure NOS 2
Vocalisation 2
Death by euthanasia 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Behavioural disorder NOS 2
Disorientation 1
Elevated serum alkaline phosphatase (SAP) 1
Elevated alanine aminotransferase (ALT) 1
Inappetence 1

Outcome Breakdown

Outcome Unknown
8 (57.1%)
Recovered/Normal
3 (21.4%)
Euthanized
2 (14.3%)
Ongoing
1 (7.1%)

Data Summary

Metric Value
Total adverse event reports 14
Reports involving death 2
Case-fatality rate (reported events) 1430.0%
Distinct species in reports 2
Distinct breeds in reports 10
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Allergy Medication Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 14 adverse event reports referencing Allergy Medication, including 2 reports in which the animal died — a 1430.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Allergy Medication. Reported administration routes include Unknown, Oral, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Allergy Medication reports are Dog (12 reports), Cat (2 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (3), Terrier - Yorkshire (2), Domestic Shorthair (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Allergy Medication are Lack of efficacy (ectoparasite) - flea (5), Vomiting (3), Pruritus (3), Seizure NOS (2). Of the 14 reports with a coded outcome, Outcome Unknown is the leading category at 57.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Allergy Medication.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial